Name | 4-[3-[3-[4-(4-fluorobenzoyl)piperidin-1-yl]propoxy]-4-methoxyphenyl]pyrrolidin-2-one |
---|---|
Synonyms |
4-(3-{3-[4-(4-fluorobenzoyl)piperidin-1-yl]propoxy}-4-methoxyphenyl)pyrrolidin-2-one
Lidanserinum Lidanserin Lidanserine ( inverted exclamation markA)-4-(3-(3-(4-(p-fluorobenzoyl)piperidino)propoxy)-4-methoxyphenyl)-2-pyrrolidinone Lidanserina Lidanserine [INN-French] |
Description | Lidanserin is a drug which acts as a combined 5-HT2A and α1-adrenergic receptor antagonist. |
---|---|
Related Catalog | |
Target |
5-HT2AA and α1-adrenergic receptor |
In Vitro | Lidanserin is a combined 5-HT2A and α1-adrenergic receptor antagonist. Lidanserin is uaed as an antihypertensive agent. |
Density | 1.192g/cm3 |
---|---|
Boiling Point | 658.6ºC at 760 mmHg |
Molecular Formula | C26H31FN2O4 |
Molecular Weight | 454.53400 |
Flash Point | 352.1ºC |
Exact Mass | 454.22700 |
PSA | 67.87000 |
LogP | 4.06830 |
Index of Refraction | 1.56 |
Storage condition | 2-8℃ |